XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Sales, net $ 17,308 $ 14,180 $ 49,690 $ 43,812
Cost of sales 6,730 5,726 19,068 17,959
Gross profit 10,578 8,454 30,622 25,853
Operating expenses:        
Sales and marketing 7,221 5,223 19,711 14,629
Research and development 996 841 2,787 2,545
General and administrative 11,202 6,586 29,881 22,452
Total operating expenses 19,419 12,650 52,379 39,626
Operating loss (8,841) (4,196) (21,757) (13,773)
Interest expense, net (15) (19) (46) (55)
Net loss $ (8,856) $ (4,215) $ (21,803) $ (13,828)
Basic loss per common share (in dollars per share) $ (0.13) $ (0.07) $ (0.33) $ (0.23)
Diluted loss per common share (in dollars per share) $ (0.13) $ (0.07) $ (0.33) $ (0.23)
Basic weighted average common shares outstanding (in shares) 68,236 61,695 66,811 60,797
Diluted weighted average common shares outstanding (in shares) 68,236 61,695 66,811 60,797